Skip to main content

Journal metrics

Immunology and Clinical & Experimental Immunology both rank highly in the immunology field, and have rising impact factors (IFs).

The latest impact factors were released in June 2020, when Immunology reached an IF of 5.016 and Clinical & Experimental Immunology achieved an IF of 3.532.

Whilst we are aware that the impact factor has certain limitations, we take this as one measure of the high quality work submitted by our authors, contributing highly cited reviews and research, which we have highlighted here.

We are continuing to achieve our goal of publishing content which is timely and relevant to our research community, as demonstrated by the high Altmetric scores and downloads of our articles.

Other metrics

Clinical & Experimental Immunology
  • Mean time to first decision: 16 days
  • Mean time to final decision: 31 days
  • Average monthly usage: 52,853 full text downloads
  • 5 year impact factor: 3.472
  • Immediacy index: 1.397
  • Mean time to first decision: 22 days
  • Mean time to final decision: 39 days
  • Average monthly usage: 49,877 full text downloads
  • 5 year impact factor: 4.324
  • Immediacy index: 1.234

You can find more information about our journals here: ImmunologyClinical & Experimental Immunology and Immunotherapy Advances. We offer a broad suite of additional benefits to authors, including a very rapid time to first decision, live Altmetric tracking on your articles, no page charges for members, integration with Publons, and the skills of a dedicated marketing team who will promote your article to interested parties.

Profits derived from the sale of the journals are invested back into the BSI to benefit our members in the form of grants, travel awards, Regional and Affinity Group meetings, our popular annual Congress and other key initiatives. We encourage you to support the BSI by submitting your work.

Please note that from 2022 the journal Immunology will no longer be affiliated with the British Society for Immunology and as such, the profits derived from the journal will no longer contribute to the Society. Read the full announcement from BSI President, Professor Arne Akbar. If you have any questions about how these changes will affect you, please take a look at our FAQs.

You can share your papers online and keep up to date with news from the journals by following @immjournal@CEIjournal and @IMTadvances on Twitter.